StimCell Energetics Partners With ADM Tronics to Redesign eBalance Microcurrent Device for Home Use
StimCell Energetics (OTC PINK:STME) has partnered with ADM Tronics Unlimited (ADMT) to redesign their eBalance® microcurrent device for home use. The new version will be more compact and cost-effective, featuring advanced diagnostic capabilities including real-time cellular energy capacity assessment, treatment tracking, and personalized user profiles.
The eBalance® device utilizes frequency-specific microcurrent technology to stimulate cellular function and promote ATP production, targeting anti-aging, pain relief, and overall vitality. The redesigned consumer unit aims to make this clinical-grade technology more accessible while maintaining its effectiveness in enhancing the body's natural regenerative processes.
StimCell Energetics (OTC PINK:STME) ha stretto una partnership con ADM Tronics Unlimited (ADMT) per riprogettare il loro dispositivo eBalance® microcurrent per uso domestico. La nuova versione sarà più compatta ed economica, con avanzate capacità diagnostiche che includono la valutazione in tempo reale della capacità energetica cellulare, il monitoraggio dei trattamenti e profili utente personalizzati.
Il dispositivo eBalance® utilizza la tecnologia microcorrente a frequenza specifica per stimolare la funzione cellulare e promuovere la produzione di ATP, mirando all'anti-invecchiamento, al sollievo dal dolore e alla vitalità complessiva. L'unità consumer riprogettata mira a rendere questa tecnologia di grado clinico più accessibile, mantenendo al contempo la sua efficacia nel potenziare i processi rigenerativi naturali del corpo.
StimCell Energetics (OTC PINK:STME) se ha asociado con ADM Tronics Unlimited (ADMT) para rediseñar su dispositivo eBalance® microcurrent para uso doméstico. La nueva versión será más compacta y rentable, con capacidades diagnósticas avanzadas que incluyen la evaluación en tiempo real de la capacidad energética celular, el seguimiento de tratamientos y perfiles de usuario personalizados.
El dispositivo eBalance® utiliza tecnología de microcorriente específica de frecuencia para estimular la función celular y promover la producción de ATP, enfocándose en el antienvejecimiento, el alivio del dolor y la vitalidad general. La unidad de consumo rediseñada tiene como objetivo hacer que esta tecnología de grado clínico sea más accesible, manteniendo su efectividad en la mejora de los procesos regenerativos naturales del cuerpo.
StimCell Energetics (OTC PINK:STME)는 ADM Tronics Unlimited (ADMT)와 협력하여 가정용 eBalance® 마이크로 전류 장치를 재설계했습니다. 새로운 버전은 더 작고 비용 효율적이며, 실시간 세포 에너지 용량 평가, 치료 추적 및 개인화된 사용자 프로필을 포함한 고급 진단 기능을 갖추고 있습니다.
eBalance® 장치는 주파수 특정 마이크로 전류 기술을 활용하여 세포 기능을 자극하고 ATP 생산을 촉진하며, 노화 방지, 통증 완화 및 전반적인 활력을 목표로 합니다. 재설계된 소비자 유닛은 이 임상 등급 기술을 더 접근 가능하게 만드는 것을 목표로 하며, 신체의 자연적인 재생 과정을 향상시키는 효과를 유지합니다.
StimCell Energetics (OTC PINK:STME) a établi un partenariat avec ADM Tronics Unlimited (ADMT) pour redessiner leur dispositif eBalance® microcurrent pour un usage domestique. La nouvelle version sera plus compacte et économique, avec des capacités de diagnostic avancées, y compris l'évaluation en temps réel de la capacité énergétique cellulaire, le suivi des traitements et des profils d'utilisateur personnalisés.
Le dispositif eBalance® utilise une technologie de microcourant spécifique à la fréquence pour stimuler la fonction cellulaire et promouvoir la production d'ATP, ciblant le vieillissement, le soulagement de la douleur et la vitalité globale. L'unité de consommation redessinée vise à rendre cette technologie de niveau clinique plus accessible tout en maintenant son efficacité à améliorer les processus régénératifs naturels du corps.
StimCell Energetics (OTC PINK:STME) hat sich mit ADM Tronics Unlimited (ADMT) zusammengeschlossen, um ihr eBalance® Mikroströmungsgerät für den Heimgebrauch neu zu gestalten. Die neue Version wird kompakter und kostengünstiger sein und über fortschrittliche diagnostische Fähigkeiten verfügen, darunter die Echtzeiteinschätzung der zellulären Energiekapazität, die Behandlungstracking und personalisierte Benutzerprofile.
Das eBalance®-Gerät nutzt frequenzspezifische Mikroströmungstechnologie, um die Zellfunktion zu stimulieren und die ATP-Produktion zu fördern, mit dem Ziel der Anti-Aging-Behandlung, Schmerzlinderung und allgemeiner Vitalität. Die neu gestaltete Verbrauchereinheit soll diese klinisch getestete Technologie zugänglicher machen, während ihre Wirksamkeit zur Verbesserung der natürlichen regenerativen Prozesse des Körpers erhalten bleibt.
- Partnership with established medical device engineering company ADMT
- Product improvement with advanced diagnostic features
- Expansion into consumer market with more accessible pricing
- Cost reduction in manufacturing new version
- None.
Innovative Redesign Brings Smaller, Cost-Effective Unit with Advanced Diagnostics to Consumers
VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / February 25, 2025 / StimCell Energetics Inc. (OTC PINK:STME) ("StimCell" or the "Company"), a biotech pioneer targeting cellular energy to enhance wellness, anti-aging, and longevity, is thrilled to announce a new partnership with ADM Tronics Unlimited, Inc., (ADMT) a leader in electronic medical device engineering. This collaboration aims to redesign StimCell's proprietary eBalance® microcurrent device, transforming it into a compact, affordable consumer unit optimized for home use, complete with cutting-edge diagnostic features.
The redesigned eBalance® is targeted to empower individuals to take control of their health from the comfort of home. The new version will be smaller and more cost-efficient than its predecessors, making advanced microcurrent technology accessible to a broader audience. Additionally, it will feature innovative diagnostics, including a real-time assessment of cellular energy capacity, treatment tracking, and personalized user profiles-capabilities that set it apart in the wellness technology market.
The eBalance® device is extraordinary for its ability to harness frequency-specific microcurrent to stimulate cellular function, promoting ATP production-the energy currency of cells. This non-invasive technology aims to support anti-aging, pain relief, and overall vitality by enhancing the body's natural regenerative processes. With this redesign, StimCell is poised to redefine how consumers approach wellness, bridging the gap between clinical-grade solutions and everyday home care.
"We're incredibly excited to partner with ADM Tronics to bring this next-generation eBalance® to life," said David Jeffs, CEO of StimCell Energetics Inc. "This redesign reflects our commitment to making cellular energy optimization accessible to everyone. By shrinking the size, reducing costs, and adding diagnostics like cellular energy tracking, we're giving users a powerful lifestyle tool to monitor and enhance their well-being in real-time-right at home."
About ADM Tronics Unlimited, Inc.
ADM Tronics is a premier engineering and manufacturing firm specializing in therapeutic and diagnostic electronic medical devices. With decades of experience navigating regulatory landscapes and delivering innovative solutions, ADM Tronics partners with companies to bring cutting-edge technology to market.
André DiMino, CEO of ADM Tronics, stated: "Collaborating with StimCell Energetics on the eBalance® redesign is a fantastic opportunity to leverage our expertise in medical device innovation. This project combines advanced engineering with a vision for consumer empowerment, delivering a smaller, smarter, and more affordable device that doesn't compromise on performance. We're proud to help bring this transformative technology to households everywhere."
StimCell Energetics continues to lead in cellular energetics, focusing on the development and commercialization of products that enhance cellular function and alleviate health challenges such as aging and chronic conditions such as insulin resistance and blood pressure. The partnership with ADM Tronics marks a significant step forward in making the eBalance® a household name in wellness innovation.
About StimCell Energetics Inc.
StimCell Energetics Inc. is a biotech company focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness and alleviate health complications including, but not limited to: aging, insulin sensitivity, high blood pressure, neuropathy and kidney function. The Company's main focus is on continued research and development of its eBalance® Technology and its eBalance® Home System.
On behalf of the Board of Directors of StimCell Energetics Inc.
David Jeffs
Director, CEO
For further information:
info@stimcell.com
www.StimCell.com .
Forward Looking Statements
This press release contains forward-looking statements. Forward-looking statements are subject to risks, uncertainties and assumptions and are identified by words such as "expects", "intends", "estimates", "projects", "anticipates", "believes", "could", and other similar words. All statements addressing product performance, events, or developments that the Company expects or anticipates will occur in the future are forward-looking statements. Because the statements are forward-looking, they should be evaluated in light of important risk factors and uncertainties, some of which are described in the Company's Quarterly, Annual and Current Reports filed with the United States Securities and Exchange Commission (the "SEC"). Should one or more of these risks or uncertainties materialize, or should any of the Company's underlying assumptions prove incorrect, actual results may vary materially from those currently anticipated. In addition, undue reliance should not be placed on Company's forward-looking statements. Except as required by law, StimCell Energetics Corp. disclaims any obligation to update or publicly announce any revisions to any of the forward-looking statements contained in this press release. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. No stock exchange, securities commission or other regulatory body has reviewed nor accepts responsibility for the adequacy or accuracy of this release. Investors are advised to carefully review the reports and documents that StimCell Energetics Inc. files from time to time with the SEC, including its Annual, Quarterly and Current Reports.
SOURCE: StimCell Energetics
View the original press release on ACCESS Newswire
FAQ
What new features will the redesigned STME eBalance device include?
How does the STME eBalance microcurrent device work?
What is the purpose of STME's partnership with ADM Tronics?
What are the main benefits of the new STME eBalance home device?
